Friday, 16 October 2026European Markets

IMMOBEL And 3 Other Stocks Have Very High Payout Ratio

Loading stream...

(vianews) - immobel (immo.br), abg sundal collier (abg.ol), pareto bank (parb.ol) are the highest payout ratio stocks on this list.

here's the data we've collected of stocks with a high payout ratio so far. the payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

when investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. immobel (immo.br)

283.72% payout ratio

immobel sa engages in the real estate development business in belgium, luxemburg, france, germany, poland, and spain. the company undertakes office, residential, and retail projects, as well as develops real estate projects for living, working, and recreational activities. it also provides project management and leasing services. the company was formerly known as allfin nv and changed its name to immobel sa in june 2016. the company was incorporated in 1863 and is headquartered in brussels, belgium.

earnings per share

as for profitability, immobel has a trailing twelve months eps of €1.08.

pe ratio

immobel has a trailing twelve months price to earnings ratio of 35.42. meaning, the purchaser of the share is investing €35.42 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.79%.

yearly top and bottom value

immobel's stock is valued at €38.25 at 22:10 est, below its 52-week low of €39.00.

more news about immobel.

2. abg sundal collier (abg.ol)

222.22% payout ratio

abg sundal collier holding asa, together with its subsidiaries, provides investment banking, stockbroking, and corporate advisory services in norway, sweden, denmark, and internationally. the company offers corporate financing services for corporate clients to raise capital through equity or debt financing. it is also involved in advising companies in relation to mergers, acquisitions, and sales, as well as to various real asset transactions and other advisory services. in addition, the company provides secondary security brokerage and research services. the company was founded in 1984 and is headquartered in oslo, norway.

earnings per share

as for profitability, abg sundal collier has a trailing twelve months eps of kr0.45.

pe ratio

abg sundal collier has a trailing twelve months price to earnings ratio of 12.27. meaning, the purchaser of the share is investing kr12.27 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.81%.

yearly top and bottom value

abg sundal collier's stock is valued at kr5.52 at 22:10 est, way under its 52-week high of kr7.05 and higher than its 52-week low of kr5.37.

more news about abg sundal collier.

3. pareto bank (parb.ol)

49.11% payout ratio

pareto bank asa offers various banking products and services in norway. the company accepts corporate deposits. it also offers corporate financing; receivables financing; residential and commercial financing for land and property; ship financing, including corporate and project financing; and other private or housing loans. the company was incorporated in 2007 and is headquartered in oslo, norway.

earnings per share

as for profitability, pareto bank has a trailing twelve months eps of kr7.86.

pe ratio

pareto bank has a trailing twelve months price to earnings ratio of 6.32. meaning, the purchaser of the share is investing kr6.32 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.03%.

more news about pareto bank.

4. bic (bb.pa)

45.84% payout ratio

société bic sa manufactures and sells stationery, lighter, shaver, and other products worldwide. it offers ball and coloring felt pens, gel ink pens, markers, sticky notes, leads, whiteboards, and correction tapes, as well as graphite, coloring, mechanical, and other pencils; reusable notebooks, digital slates, and smart pens; art and craft kits; permanent and temporary tattoo markers; and pen and pencil refills. the company also provides refillable shavers and razors; and pocket, utility, and decorated lighters. in addition, it sells batteries and shaving preps; and advertising and promotional products. further, the company is involved in the provision of delivery services; production of industrial equipment; and manufacture and distribution of it solutions and consumer products, as well as in real estate and insurance activities. it markets its products primarily under the bic, bic kids, cello, lucky, rocketbook, tipp-ex, bic wite-out, tattly, ami, djeep, inkbox, bic soleil, bic evolution, and bodymark brands through a range of channels, including retail mass-market distributors, traditional stores, and office product stationers, as well as an e-commerce site. the company was founded in 1944 and is headquartered in clichy, france.

earnings per share

as for profitability, bic has a trailing twelve months eps of €4.69.

pe ratio

bic has a trailing twelve months price to earnings ratio of 11.47. meaning, the purchaser of the share is investing €11.47 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.27%.

volume

today's last reported volume for bic is 11712 which is 73.76% below its average volume of 44650.

more news about bic.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com